This content is in French.
Methotrexate in juvenile idiopathic arthritis
14 février 2024
In children, the most common rheumatic disease is juvenile idiopathic arthritis. In this update of a 2001 Cochrane review, researchers assessed the value of methotrexate in children and adolescents with juvenile idiopathic arthritis. Three additional trials…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Joachim Tan et al. Methotrexate for juvenile idiopathic arthritis. Cochrane Database Syst Rev. 2024 Feb 9:2:CD003129.
View the source
